Another issue with pharmaceutical funding has been the lack of
development of new classes of drugs in response to the growth of antibiotic resistance.
The results of this study provide a new window toward
the development of a new class of drugs with a novel target unexplored until now,» said corresponding author Pietro Cottone, PhD, co-director of the Laboratory of Addictive Disorders (LAD) and associate professor of pharmacology and psychiatry at BUSM.
Resources poured into
the development of new classes of drugs.
Not exact matches
It would build expertise and develop technology platforms to support
drug development, while pursuing a
new class of large - molecule biological
drugs tailored to certain conditions, enabling the long - sought dream
of personalized medicine.
The University
of Tokyo conducts world -
class interdisciplinary research, emphasizing translational applications and
drug development with its
new facilities.
Given existing antidepressants don't work for many people, the excitement surrounding the
development of a
new class of treatments from recreational
drugs such as magic mushrooms is understandable.
«This study is the first step in a potential
drug development for a
new class of drugs for osteoarthritis, although there are a number
of hurdles we have to go through — necessarily so — before it gets nearer patients.
This knowledge opens up
new avenues to study unique stages
of infectious cycle that are affected by inhibitor
classes towards anti-parasitic
drug development.
«Furthermore, they demonstrate that a
new chemical
class binds to an alternative site on the enzyme, which overcomes existing
drug resistance and opens up the exciting possibility for
development of a novel
class of anti-TB
drugs.»
The first three - dimensional image capturing a critical malaria «conductor» protein could lead to the
development of a
new class of antimalarial
drugs.
A
new class of drugs under
development to treat depression has shown some success by targeting brain cells» ability to respond to the chemical messenger glutamate.
Tu also received numerous awards nationally which include «Award for Progress in Anti-malarial Research Achieved by Project 523 Scientific Team» honored by China National Congress
of Science and Technology (1978); «National Scientific Discovery Award» for Anti-malaria
Drug - Qinghaosu by the China Ministry
of Science and Technology (1979); «Invention Award» (as the first inventor) by China National Congress for Awards in Science and Technology (1982); «Award
of Young and Middle - aged Experts with Outstanding Contribution» by the Chinese Government (1984); «The Top Honorary Award» by China Academy
of Traditional Chinese Medicine (1992); «The Top Ten National Achievements for Progress in Science and Technology» by China National Committee
of Science and Technology (1992); «First -
Class Award
of National Achievements in Science and Technology» by China National Award Committee for Advances in Science and Technology (1992); «National Model» by China State Council (1995); «Award for Outstanding Achievement in Traditional Chinese Medicine» by Guangzhou Zhongjing Award Foundation for Traditional Chinese Medicine (1995); «Outstanding Scientific Achievement Award» by Qiu Shi Science and Technologies Foundation
of Hong Kong (1996); «Top Ten Health Achievements in
New China» by China Ministry
of Health (1997); «Female Inventor
of the
New Century» by China National Bureau
of Intellectual Property (2002); «Golden Medal
of the 14th National Invention Exhibition» by China National Bureau
of Intellectual Property (2003); «Award for
Development of Chinese Materia Medica» by Cyrus Chung Ying Tang Foundation, (2009).
Ten years later, Ashworth identified a way to exploit genetic weaknesses in cancer cells that include mutated BRCA2, which led to the
development of a successful
new class of cancer
drugs known as PARP inhibitors.
Dr. Vilcek's contributions to the understanding
of proteins that control the body's defenses were instrumental in the
development of the anti-inflammatory
drug Remicade ®, the first member
of a
new class of therapeutics called TNF blockers that are now widely used for the treatment
of Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, and other chronic inflammatory disorders.
LA JOLLA — Tony Hunter, professor and director
of the Salk Institute Cancer Center, in La Jolla, California, has received the BBVA Foundation Frontiers
of Knowledge Award in the Biomedicine category for «carving out the path that led to the
development of a
new class of successful cancer
drugs.»
31 Units
of PSHE Lessons - suitable for all year groups Differentiated learning objectives Worksheets (differentiated) Clips included if appropriate Engaging activities The following units are covered; Alcohol Aspiration Body image and eating disorders Bullying or banter
Drugs -
Class A, B and C
Drugs and the law Employment and careers Enterprise and entrepreneurs FGM and sexual health Finance Friendship Healthy living and eating LGBT and homophobia Mental health Mindfulness Money
New Years Resolutions Online grooming and internet safety Peer pressure Personal
development and self discipline Personal hygiene Politics Racism - stereotypes and diversity Resilience Revision and exam study skills Rights and responsibilies Safe students Self - esteem Sex and relationships Sexism, gender stereotypes and prejudice